Yes, I was asking the same thing earlier but nobody picked up on it.
It seems there is at least some question on the vector or a HBV trial would be a lot closer. It occurs to me that this is why Bionomics are holding off.
Perhaps Benitec want to take advantage of any future work or new development in AAV.
Add to My Watchlist
What is My Watchlist?